Markowitz Wayne
CVP, JAPAC
Markowitz Wayne has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.
On the most recent filing, Markowitz Wayne is listed as CVP, JAPAC at Edwards Lifesciences Corp. Inside the rolling window, Markowitz Wayne reported no open-market purchases and 5 open-market sales totaling $1.0M in EW. The largest disclosed transaction in the window is a sale of 9,628 EW shares on Jul 28, 2026, worth $819K.
Companies traded
Other insiders at EW
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Markowitz Wayne made?
Markowitz Wayne has filed 7 SEC Form 4 filings (13 transaction rows) across 1 company since 2025.
Which companies does Markowitz Wayne trade?
Markowitz Wayne has filed SEC Form 4 disclosures for 1 company, including EW.
When was Markowitz Wayne's most recent SEC Form 4 filing?
Markowitz Wayne's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.
What is Markowitz Wayne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Markowitz Wayne is listed as CVP, JAPAC.
What is Markowitz Wayne's total buy and sell value in the current window?
Inside the rolling retention window, Markowitz Wayne bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Markowitz Wayne's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,628 EW shares on 2026-07-28, worth $819K, per SEC Form 4 filings.